NCT01111994View on ClinicalTrials.gov

Efficacy & Safety of Clindamycin and Tretinoin in Acne

PHASE4UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions
Acne
Interventions
DRUG

Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel

Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel QD for 3 months

Trial Locations (2)

19107

Society Hill Dermatology, Philadelphia

20721

Callender Center for Clinical Research, Mitchellville

Sponsors
All Listed Sponsors
collaborator

Society Hill Dermatology

OTHER

lead

Callender Center for Clinical Research

OTHER